ADVERSE EVENTS FOLLOWING IMMUNIZATION AEFI - PowerPoint PPT Presentation

1 / 28
About This Presentation
Title:

ADVERSE EVENTS FOLLOWING IMMUNIZATION AEFI

Description:

Vaccine reactions- anaphylaxis. Programme errors-poor injection technique ... but more serious reactions eg anaphylaxis,and vaccine specific reaction eg ... – PowerPoint PPT presentation

Number of Views:3683
Avg rating:3.0/5.0
Slides: 29
Provided by: nesi
Category:

less

Transcript and Presenter's Notes

Title: ADVERSE EVENTS FOLLOWING IMMUNIZATION AEFI


1
ADVERSE EVENTS FOLLOWING IMMUNIZATION (AEFI)
  • Group 1

2
Immunization safety is now an emerging issue, WHY?
  • Injection safety is not a guarantee in many
    countries
  • Regulations related to use of medication are not
    in place
  • There is inadequate monitoring of immunisation
    programmes
  • Lack of sensitization on immunisation
  • There is increasing number of new vaccines

3
Immunization safety is now an emerging issue
  • Injection safety is not a guarantee in many
    countries
  • Regulations related to use of medication are in
    place
  • There is inadequate monitoring of immunisation
    programmes
  • Lack of senstisation on immunisation
  • There is increasing number of new vaccines
  • Anti-immunisation campaign lobby

4
What is AEFI?
  • Medical incident that takes place after an
    immunisation which causes concern and is believed
    to be caused by immuniastion (WHO)

5
Categories of AEFI
  • Vaccine reactions- anaphylaxis
  • Programme errors-poor injection technique
  • coincidental effects-malaria
  • Injection reaction- pain
  • Unknown

6
Types of AEFI
  • Common minor reactions-pain, fever,local reaction
  • Rare but more serious reactions eg
    anaphylaxis,and vaccine specific reaction eg
    paralytic polio

7
Intervention for Rare AEFI
  • Need to acknowledge the event
  • Investigate thoroughly
  • Take appropriate action
  • Never rash to make a decision(?costly)
  • Need to put in place Nat.Regulatory body to look
    into safety and efficacy of vaccines-training,fee
    dback,create capacity to detect and assess AEFI
    and provision for post marketing surveillance

8
Journalism and Health
  • Media can promote or hinder the development of a
    health system/programme
  • Characteristics of Media- it acts very fast, it
    is a business,sensational headlines, argue in the
    interest of the public,
  • Good working relationship improves positive
    output and public image

9
Why journalism and Health?
  • Both work for the good of the public and are
    professions
  • Both favour the children
  • However, in case of AEFI media collect
    information from parents rather than health
    worker which they publish immediately
  • H/workers have a negative attitude towards media

10
Summary
  • It is important to have a monitoring system in
    every country for AEFI
  • Effective communication is important
  • Prompt reporting of events is critical in the
    successful management of AEFI system
  • Follow up and corrective action are essential
    including surveillance system
  • Positive relationship with the media,essential
  • Investigate issues before taking action

11
END
  • Thank you for listening

12
(No Transcript)
13
(No Transcript)
14
Evaluation of Hep B immunisation Programme in
Gorin
  • Group 3
  • Facilitators P.Zuber,T.Manzila and A.Meheus

15
Process/ Introduction
  • Facilitator introduced the assignment
  • Informed pax that benefits of Hep B occur 30
    years later after immunisation
  • It was revealed that there was no standard tool
    (WHO) to assess the impact of Hep B
  • PAX were requested to read the case study

16
Learning objectives
  • Describe a strategy for assessing the impact of
    Hep B immunisation including the role of
    sero-surveys
  • Describe the specific Hep B coverage measures to
    be evaluated and their interpretation
  • Describe the specific HBV sero-markers and their
    interpretation
  • Make a presentation on the impact EPI

17
Progress
  • The exercise was interactive and was done in a
    stepwise manner, answering, questions as more
    information was revealed to pax

18
Summary of the case study
  • Gorin, in central Asia, hadstrong EPI Prog.
  • Gorin had high prevalence of HBsAg 15
  • Despite the high cost,G had introduced Hep B
    immunisation as Hep B disease was a leading cause
    of death in men
  • In 2003,Hon MOH read an article (High Hepatitis
    markers in Kids of 5-10yrs) that concluded that
    HepB immunisation was not effective

19
Summary Contd
  • Hon MOH asked EPI Manager for more information
    about the impact of Hep B immunisation
  • Hon MOH was upset and threatened to biopsy the
    liver/ EPI Manager if the programme did not
    protect Gorinese children
  • EPI Manager in Panic sought for help from RWG
    special Consultant

20
What information from E/Mnger
  • Coverage,training of service providers-efficiency
    of cold chain system-stock outs-new born
    immunised-schedule-prevalence determined before
    introduction-population comparable urban vs rural
    of the sero-survey

21
More information by EPI Mng
  • Pre-vaccine -era- HBsAg pregnant15
  • Kids 3-6yrs14 Introduced in 1990
  • HepB vaccine given 24 hrs of delivery
  • Coverage HepB-197,296,3,84
  • Trained H/workers
  • No evidence of Freezing
  • Had a successful DQA

22
Any more information?
  • Are there similar studies
  • What serological markers were looked at?
  • Pax-noted- Available information was accurate
    vertical transmission, No apparent programmatic
    gaps,

Pax recommended repeat of the study in Gorin
23
Comment on Gorin strategy and compare with other
regions
  • Gorin strategy was correct as vertical
    transmission is common in Asia while Horizontal
    transmission is more common in Africa

24
What Progr.can affect HepB immunisation
  • Poor cold chain
  • Injection technique(sero-conversion)- sc vs im,vs
    fatty tissue
  • Low coverage
  • Birth dose given beyond 4 days
  • Limited facility delivery

25
Similar Studies Elsewhere
  • Consultant prepared a table showing - sample
    size,age bracket,coverage, prevalence before and
    after introduction
  • 14 studies showed drastic reduction in chronic
    infection fromgt10 to 0-2.9 WHILE Gorin was 12
    after introduction

26
Additional information arrived
  • Hepatitis marker No positive positive
  • HBsAg 33/225
    12
  • Anti-HBs 183/225
    81
  • Total Anti-HBc 7/225 2

27
Interpretation of the table
  • Immunisation was doing well (anti-HBs)
  • ? HBsAg was so high vs ant-HBc (doesnt happen)
  • Pax recommended repeat of the study in Gorin due
    to inconsistence

28
Whose liver should be biopsied?
  • Correct Answer gets a gift !!!!!!!
  • Discuss..
  • Thank u
Write a Comment
User Comments (0)
About PowerShow.com